| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |